To include your compound in the COVID-19 Resource Center, submit it here.

Dacogen decitabine: Additional Phase III data

Additional data from an open-label, international Phase III trial in 485 elderly patients with AML showed that Dacogen led to a median OS, the

Read the full 249 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE